Quick Answer
INTERPACE BIOSCIENCES, INC. reported Operating Income of $4.08 million for fiscal year 2025.
INTERPACE BIOSCIENCES, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $4.08M | -49.6% |
| 2024 | $8.11M | +105.0% |
| 2023 | $3.96M | +209.4% |
| 2022 | -$3.62M | +42.9% |
| 2021 | -$6.34M | +75.7% |
| 2020 | -$26.07M | +1.4% |
| 2019 | -$26.44M | -118.1% |
| 2018 | -$12.12M | -92.6% |
| 2017 | -$6.29M | +2.3% |
| 2016 | -$6.44M | +84.1% |
| 2015 | -$40.41M | -126.7% |
| 2014 | -$17.83M | -1140.5% |
| 2013 | -$1.44M | +94.3% |
| 2012 | -$25.23M | -436.6% |
| 2011 | -$4.70M | +31.9% |
| 2010 | -$6.90M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.15M | -50.2% | +344.7% |
| June 30, 2025 | -$468.0K | -117.8% | -125.6% |
| March 31, 2025 | $1.83M | +64.2% | -20.5% |
| September 30, 2024 | $2.30M | +14481.2% | -12.6% |
| June 30, 2024 | $2.63M | +216.3% | +136.3% |
| March 31, 2024 | $1.11M | +65.0% | +7062.5% |
| September 30, 2023 | -$16.0K | +97.9% | -101.9% |
| June 30, 2023 | $832.0K | +143.5% | +23.3% |
- INTERPACE BIOSCIENCES, INC. showed a decrease of -49.6% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, INTERPACE BIOSCIENCES, INC.’s operating income has grown by 159.2% (from -$6.90 million to $4.08 million).
- The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: